mutLBSgeneDB |
Gene summary for CASP1 |
Gene summary |
Basic gene Info. | Gene symbol | CASP1 |
Gene name | caspase 1, apoptosis-related cysteine peptidase | |
Synonyms | ICE|IL1BC|P45 | |
Cytomap | UCSC genome browser: 11q23 | |
Type of gene | protein-coding | |
RefGenes | NM_001223.4, NM_001257118.2,NM_001257119.2,NM_033292.3,NM_033293.3, NM_033294.3,NM_033295.3, | |
Description | CASP1 nirs variant 1IL-1 beta-converting enzymeIL1B-convertasecaspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)caspase-1interleukin 1, beta, convertaseinterleukin 1-B converting enzyme | |
Modification date | 20141222 | |
dbXrefs | MIM : 147678 | |
HGNC : HGNC | ||
Ensembl : ENSG00000137752 | ||
HPRD : 00977 | ||
Vega : OTTHUMG00000048072 | ||
Protein | UniProt: P29466 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CASP1 | |
BioGPS: 834 | ||
Pathway | NCI Pathway Interaction Database: CASP1 | |
KEGG: CASP1 | ||
REACTOME: CASP1 | ||
Pathway Commons: CASP1 | ||
Context | iHOP: CASP1 | |
ligand binding site mutation search in PubMed: CASP1 | ||
UCL Cancer Institute: CASP1 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0006508 | proteolysis | 12888622 | GO:0071310 | cellular response to organic substance | 19158679 |
Top |
Ligand binding site mutations for CASP1 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | C331 | A329T | COAD | 1 | M345 | M345I | LUAD | 1 | E390 | T388N | LUAD | 1 | E390 | E390K | LUAD | 1 | C331 | A329T | OV | 1 | C331 | C331W | PRAD | 1 | S236 | S236F | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for CASP1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | E390 | E390K | -1.105366 | S236 | S236F | -1.0525217 | E390 | T388N | -1.0299225 | C331 | A329T | -0.97484169 | M345 | M345I | -0.41398124 | C331 | C331W | -0.30397525 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for CASP1 from PDB |
Top |
Differential gene expression and gene-gene network for CASP1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for CASP1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C1862939 | Amyotrophic lateral sclerosis 1 | 3 | Biomarker, GeneticVariation |
umls:C0032285 | Pneumonia | 3 | Biomarker |
umls:C0001925 | Albuminuria | 1 | Biomarker |
umls:C0598608 | Hyperhomocysteinemia | 1 | Biomarker |
umls:C0020517 | Hypersensitivity | 1 | Biomarker |
umls:C0021368 | Inflammation | 1 | Biomarker |
umls:C0021655 | Insulin Resistance | 1 | Biomarker |
umls:C0022658 | Kidney Diseases | 1 | Biomarker |
umls:C0027055 | Myocardial Reperfusion Injury | 1 | Biomarker |
umls:C0028754 | Obesity | 1 | Biomarker |
umls:C0038220 | Status Epilepticus | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for CASP1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Approved|investigational | DB01017 | Minocycline | Small molecule | |
Investigational | DB04875 | Pralnacasan | Small molecule | |
Investigational | DB05301 | LAX-101 | Small molecule | |
Investigational | DB05408 | IDN-6556 | Small molecule | |
Investigational | DB05507 | VX-765 | Small molecule | |
Experimental | DB07733 | 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE | Small molecule | |
Experimental | DB07744 | 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID | Small molecule | |
Experimental | DB07916 | 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of CASP1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | F1G | 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE | 2fqq | B | C331 E390 | 4QB | 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID | 1rwn | B | M345 | BTH | 4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-PENTANOIC ACID | 1rwo | B | M345 | OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID | 1rww | B | M345 | 5PH | 5-[5-(1-CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-5-PHENYL-PENTYLSULFAMOYL]-2-HYDROXY-BENZOIC ACID | 1rwv | A | S236 | MLI | MALONATE(2-) | 1sc3 | A | S236 | III | Peptide ligand (PHQ,VAL,ALA,ASP,CF0) | 2hbr | A | S236 | 3NS | (3S)-4-HYDROXY-3-{[(2S)-4-{[2-(2-METHYL-1H-BENZIMIDAZOL-1-YL)ETHYL]AMINO}-2-(1-METHYLETHYL)-4-OXOBUTANOYL]AMINO}BUTANOIC ACID | 3ns7 | A | S236 |
Top |
Conservation information for LBS of CASP1 |
Multiple alignments for P29466 in multiple species |
LBS | AA sequence | # species | Species | A284 | VIIIQACRGDS | 1 | Homo sapiens | A284 | VIIIQACRGEN | 1 | Canis lupus familiaris | A284 | VIIIQACRGEK | 1 | Mus musculus | C285 | IIIQACRGDSP | 1 | Homo sapiens | C285 | IIIQACRGENP | 1 | Canis lupus familiaris | C285 | IIIQACRGEKQ | 1 | Mus musculus | C331 | DFIAFCSSTPD | 2 | Homo sapiens, Mus musculus | C331 | DFIAFCSSTPH | 1 | Canis lupus familiaris | D381 | SFEQPDGRAQM | 1 | Homo sapiens | D381 | SFEKPDVKAQM | 1 | Canis lupus familiaris | D381 | SFEQPEFRLQM | 1 | Mus musculus | E390 | QMPTTERVTLT | 1 | Homo sapiens | E390 | QMPTIERVSMT | 1 | Canis lupus familiaris | E390 | QMPTADRVTLT | 1 | Mus musculus | F377 | KVRFSFEQPDG | 1 | Homo sapiens | F377 | KVQQSFEKPDV | 1 | Canis lupus familiaris | F377 | KVRFSFEQPEF | 1 | Mus musculus | G238 | VFMSHGIREGI | 1 | Homo sapiens | G238 | VLMSHGILNGI | 1 | Canis lupus familiaris | G238 | VFMSHGIQEGI | 1 | Mus musculus | G346 | RHPTMGSVFIG | 1 | Homo sapiens | G346 | RHITKGSLFIA | 1 | Canis lupus familiaris | G346 | RHPVRGSLFIE | 1 | Mus musculus | H237 | LVFMSHGIREG | 1 | Homo sapiens | H237 | LVLMSHGILNG | 1 | Canis lupus familiaris | H237 | LVFMSHGIQEG | 1 | Mus musculus | H342 | NVSWRHPTMGS | 1 | Homo sapiens | H342 | NVSWRHITKGS | 1 | Canis lupus familiaris | H342 | NVSWRHPVRGS | 1 | Mus musculus | L258 | PDILQLNAIFN | 1 | Homo sapiens | L258 | PDVLAYDTIFQ | 1 | Canis lupus familiaris | L258 | SDILKVDTIFQ | 1 | Mus musculus | M345 | WRHPTMGSVFI | 1 | Homo sapiens | M345 | WRHITKGSLFI | 1 | Canis lupus familiaris | M345 | WRHPVRGSLFI | 1 | Mus musculus | P177 | EFDSIPRRTGA | 1 | Homo sapiens | P177 | EFDHLSTRDGA | 1 | Canis lupus familiaris | P177 | EFQHLSPRVGA | 1 | Mus musculus | P343 | VSWRHPTMGSV | 1 | Homo sapiens | P343 | VSWRHITKGSL | 1 | Canis lupus familiaris | P343 | VSWRHPVRGSL | 1 | Mus musculus | Q283 | KVIIIQACRGE | 2 | Canis lupus familiaris, Mus musculus | Q283 | KVIIIQACRGD | 1 | Homo sapiens | R179 | DSIPRRTGAEV | 1 | Homo sapiens | R179 | DHLSTRDGAEL | 1 | Canis lupus familiaris | R179 | QHLSPRVGAQV | 1 | Mus musculus | R286 | IIQACRGDSPG | 1 | Homo sapiens | R286 | IIQACRGENPG | 1 | Canis lupus familiaris | R286 | IIQACRGEKQG | 1 | Mus musculus | R341 | DNVSWRHPTMG | 1 | Homo sapiens | R341 | HNVSWRHITKG | 1 | Canis lupus familiaris | R341 | DNVSWRHPVRG | 1 | Mus musculus | R352 | SVFIGRLIEHM | 1 | Homo sapiens | R352 | SLFIAQLITCF | 1 | Canis lupus familiaris | R352 | SLFIESLIKHM | 1 | Mus musculus | R383 | EQPDGRAQMPT | 1 | Homo sapiens | R383 | EKPDVKAQMPT | 1 | Canis lupus familiaris | R383 | EQPEFRLQMPT | 1 | Mus musculus | S236 | FLVFMSHGIRE | 1 | Homo sapiens | S236 | FLVLMSHGILN | 1 | Canis lupus familiaris | S236 | FLVFMSHGIQE | 1 | Mus musculus | S339 | TPDNVSWRHPT | 1 | Homo sapiens | S339 | TPHNVSWRHIT | 1 | Canis lupus familiaris | S339 | TPDNVSWRHPV | 1 | Mus musculus | S347 | HPTMGSVFIGR | 1 | Homo sapiens | S347 | HITKGSLFIAQ | 1 | Canis lupus familiaris | S347 | HPVRGSLFIES | 1 | Mus musculus | V338 | STPDNVSWRHP | 2 | Homo sapiens, Mus musculus | V338 | STPHNVSWRHI | 1 | Canis lupus familiaris | V348 | PTMGSVFIGRL | 1 | Homo sapiens | V348 | ITKGSLFIAQL | 1 | Canis lupus familiaris | V348 | PVRGSLFIESL | 1 | Mus musculus | W340 | PDNVSWRHPTM | 1 | Homo sapiens | W340 | PHNVSWRHITK | 1 | Canis lupus familiaris | W340 | PDNVSWRHPVR | 1 | Mus musculus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |